| 1 |
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al. · Cancer Cell
Open access |
Feb 2013 |
874 |
| 2 |
The odyssey of marine pharmaceuticals: a current pipeline perspective
Alejandro M. S. Mayer, Keith B. Glaser, Carmen Cuevas et al. · Trends in Pharmacological Sciences
|
6 Apr 2010 |
669 |
| 3 |
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
George D. Demetri, Sant P. Chawla, Margaret von Mehren et al. · Journal of Clinical Oncology
Open access |
4 Aug 2009 |
537 |
| 4 |
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
José Manuel Trigo et al. · The Lancet Oncology
|
27 Mar 2020 |
488 |
| 5 |
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
Federica Grosso, Robin L. Jones, George D. Demetri et al. · The Lancet Oncology
|
23 Jun 2007 |
452 |
| 6 |
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
Maurizio D’Incalci, Carlos María Galmarini · Molecular Cancer Therapeutics
|
20 Jul 2010 |
450 |
| 7 |
A comparison between two brine shrimp assays to detect in vitrocytotoxicity in marine natural products
José Luís Carballo, Zaira L Hernández-Inda, Pilar Pérez et al. · BMC Biotechnology
Open access |
23 Sep 2002 |
403 |
| 8 |
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White et al. · Science
Open access |
25 Feb 2021 |
368 |
| 9 |
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
William H. Goodson et al. · Carcinogenesis
Open access173 authors |
Jun 2015 |
324 |
| 10 |
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
Carmen Cuevas, Andrés Francesch · Natural Product Reports
|
2009 |
322 |
| 11 |
Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy
Rocio García‐Carbonero, Jeff Supko, Judith B. Manola et al. · Journal of Clinical Oncology
Open access |
14 Apr 2004 |
294 |
| 12 |
Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B
Carmen Cuevas, Marta del Pozo Pérez, María Jesús Martín et al. · Organic Letters
|
19 Jul 2000 |
283 |
| 13 |
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
Andrea Enrico Prota, Katja Bargsten, José Fernando Díaz et al. · Proceedings of the National Academy of Sciences
Open access |
11 Aug 2014 |
282 |
| 14 |
Conjugate addition reactions of carbon nucleophiles to electron-deficient dienes
Aurelio G. Csákÿ, Gabriela de la Herrán, M. Carmen Murcia · Chemical Society Reviews
Review |
2010 |
278 |
| 15 |
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al. · Cancer Research
Open access |
9 Mar 2010 |
267 |
| 16 |
Marine organisms as a source of new anticancer agents
Gilberto Schwartsmann, Adriana Brondani da Rocha, Roberto G. S. Berlinck et al. · The Lancet Oncology
|
Apr 2001 |
263 |
| 17 |
Thiocoraline, a New Depsipeptide with Antitumor Activity Produced by a Marine Micromonospora. I. Taxonomy, Fermentation, Isolation, and Biological Activities.
Francisco Romero, FERNANDO ESPLIEGO, JULIA PÉREZ BAZ et al. · The Journal of Antibiotics
Open access |
1997 |
226 |
| 18 |
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
Maurizio D’Incalci, N Badri, Carlos María Galmarini et al. · British Journal of Cancer
Open access |
22 Apr 2014 |
219 |
| 19 |
Lamellarin D: a novel potent inhibitor of topoisomerase I.
Michaël Facompré, Christelle Tardy, Christine Bal-Mahieu et al. · PubMed
|
Nov 2003 |
192 |
| 20 |
Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study
Rocio García‐Carbonero, Jeffrey G. Supko, Robert G. Maki et al. · Journal of Clinical Oncology
|
18 Aug 2005 |
191 |
| 21 |
Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells.
Yajaira Suárez, Laura González, Ana Cuadrado et al. · PubMed
|
Sep 2003 |
191 |
| 22 |
Deciphering the Biosynthesis Pathway of the Antitumor Thiocoraline from a Marine Actinomycete and Its Expression in Two Streptomyces Species
Felipe Lombó, Ana Luisa Velasco, Angelina D. Castro et al. · ChemBioChem
|
12 Jan 2006 |
184 |
| 23 |
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Andres M. Poveda, Stanley B. Kaye, Robert Thomas Mccormack et al. · Gynecologic Oncology
|
25 Jun 2011 |
182 |
| 24 |
New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
José María Jimeno, Glynn T Faircloth, JM Fernández Sousa-Faro et al. · Marine Drugs
Open access |
25 Feb 2004 |
180 |
| 25 |
Unique features of trabectedin mechanism of action
Annette Kragh Larsen, Carlos María Galmarini, Maurizio D’Incalci · Cancer Chemotherapy and Pharmacology
|
14 Dec 2015 |
173 |
| 26 |
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
Andres M. Poveda, Ignace B. Vergote, Sergei Tjulandin et al. · Annals of Oncology
Open access |
20 Jul 2010 |
170 |
| 27 |
Gold Glyconanoparticles as New Tools in Antiadhesive Therapy
Javier Rojo, Vicente M. Diaz, Jesús Martínez de la Fuente et al. · ChemBioChem
|
26 Feb 2004 |
169 |
| 28 |
Prevalencia de osteoporosis determinada por densitometría en la población femenina española
Díaz Curiel M, Javier Garcia, José Luís Carrasco et al. · Medicina Clínica
|
2001 |
169 |
| 29 |
Lurbinectedin Specifically Triggers the Degradation of Phosphorylated RNA Polymerase II and the Formation of DNA Breaks in Cancer Cells
Gema Santamaría Núñez, Carlos Mario Genes Robles, Christophe Giraudon et al. · Molecular Cancer Therapeutics
|
14 Sep 2016 |
163 |
| 30 |
Cancer Cell Mitochondria Are Direct Proapoptotic Targets for the Marine Antitumor Drug Lamellarin D
Jérôme Kluza, Miguel-Angel Gallego, Anne Loyens et al. · Cancer Research
|
15 Mar 2006 |
161 |
| 31 |
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK
Ana Cuadrado, Luis García‐Fernández, Laura González et al. · Journal of Biological Chemistry
Open access |
28 Dec 2002 |
158 |
| 32 |
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti‐tumour activity
JFM Leal, Marta Martínez, Verónica García-Hernández et al. · British Journal of Pharmacology
Open access |
2 Jul 2010 |
158 |
| 33 |
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
Cristina Belgiovine, Ezia Bello, Manuela Liguori et al. · British Journal of Cancer
Open access |
6 Jul 2017 |
157 |
| 34 |
Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites
Rubén M. Buey, Enrique Calvo, Isabel Barasoaı́n et al. · Nature Chemical Biology
|
7 Jan 2007 |
153 |
| 35 |
Progress in the development and acquisition of anticancer agents from marine sources
Maria Luz Amador, José María Jimeno, Luis G Paz-Ares et al. · Annals of Oncology
Open access |
28 Oct 2003 |
152 |
| 36 |
The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers
Raquel Cuadros, Esteban Montejo de Garcini, Francisco G. Wandosell et al. · Cancer Letters
|
Apr 2000 |
151 |
| 37 |
Structure−Activity Relationships of the Didemnins
Ryuichi Sakai, Kenneth L. Rinehart, Vimal Kishore et al. · Journal of Medicinal Chemistry
|
1996 |
150 |
| 38 |
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
Alessandro Gronchi, B. Bui, Sylvie Bonvalot et al. · Annals of Oncology
Open access |
4 Jun 2011 |
148 |
| 39 |
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4
Massimo Broggini, Sergio Marchini, Emanuela Galliera et al. · Leukemia
|
2003 |
146 |
| 40 |
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas
Axel Le Cesne, Sara Cresta, Robert G. Maki et al. · European Journal of Cancer
Open access |
29 Jun 2012 |
143 |
| 41 |
In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients
Elżbieta Izbicka, Rachel A. Lawrence, Éric Raymond et al. · Annals of Oncology
Open access |
Sep 1998 |
136 |
| 42 |
Aplidin™ induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C δ
Luis García‐Fernández, Alejandro Losada, Victoria Alcaide et al. · Oncogene
|
18 Oct 2002 |
136 |
| 43 |
Thiocoraline, a Novel Depsipeptide with Antitumor Activity Produced by a Marine Micromonospora. II. Physico-chemical Properties and Structure Determination.
JULIA PÉREZ BAZ, Librada M. Cañedo, JOSÉ L. FERNÁNDEZ PUENTES et al. · The Journal of Antibiotics
Open access |
1997 |
136 |
| 44 |
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
Federica Grosso, Roberta G. Sanfilippo, Emanuela Virdis et al. · Annals of Oncology
Open access |
23 May 2009 |
131 |
| 45 |
Mode of action of trabectedin in myxoid liposarcomas
Silvia Di Giandomenico, Roberta Frapolli, Ezia Bello et al. · Oncogene
|
11 Nov 2013 |
130 |
| 46 |
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
Santiago Ponce Aix et al. · The Lancet Respiratory Medicine
Open access |
14 Oct 2022 |
125 |
| 47 |
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
Jean‐Yves Blay, Michael Gordon Leahy, Binh Bui Nguyen et al. · European Journal of Cancer
Open access |
7 Feb 2014 |
121 |
| 48 |
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou et al. · Cell
Open access |
21 Sep 2023 |
117 |
| 49 |
Batzelladine alkaloids from the caribbean sponge Monanchora unguifera and the significant activities against HIV-1 and AIDS opportunistic infectious pathogens
Huiming Hua, Jiangnan Peng, D. Chuck Dunbar et al. · Tetrahedron
|
9 Aug 2007 |
115 |
| 50 |
Isolation and First Total Synthesis of PM050489 and PM060184, Two New Marine Anticancer Compounds
María Jesús Martín, Laura Coello, Rogelio Fernández et al. · Journal of the American Chemical Society
|
10 Jun 2013 |
114 |